ALTOPREV Drug Patent Profile

✉ Email this page to a colleague

When do Altoprev patents expire, and what generic alternatives are available?

Altoprev is a drug marketed by Covis and is included in one NDA.

The generic ingredient in ALTOPREV is lovastatin. There are thirty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lovastatin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Altoprev

A generic version of ALTOPREV was approved as lovastatin by ACTAVIS ELIZABETH on December 17^th, 2001.

Sign Up

Summary for ALTOPREV

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	126
Clinical Trials:	6
Patent Applications:	4,247
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for ALTOPREV
What excipients (inactive ingredients) are in ALTOPREV?	ALTOPREV excipients list
DailyMed Link:	ALTOPREV at DailyMed

Drug patent expirations by year for ALTOPREV

Recent Clinical Trials for ALTOPREV

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Brigham and Women's Hospital	Phase 4
Amgen	Phase 4
National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2

See all ALTOPREV clinical trials

Pharmacology for ALTOPREV

Drug Class	HMG-CoA Reductase Inhibitor
Mechanism of Action	Hydroxymethylglutaryl-CoA Reductase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for ALTOPREV

C10AA	HMG CoA reductase inhibitors
C10A	LIPID MODIFYING AGENTS, PLAIN
C10	LIPID MODIFYING AGENTS
C	Cardiovascular system

US Patents and Regulatory Information for ALTOPREV

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-001	Jun 26, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-004	Jun 26, 2002		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-002	Jun 26, 2002		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-003	Jun 26, 2002		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ALTOPREV

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-004	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-001	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-001	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-004	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-002	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-004	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
Covis	ALTOPREV	lovastatin	TABLET, EXTENDED RELEASE;ORAL	021316-003	Jun 26, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ALTOPREV

See the table below for patents covering ALTOPREV around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
New Zealand	530584	HMG-COA reductase inhibitor extended release formulation	⤷ Sign Up
Canada	2324999		⤷ Sign Up
Canada	2586240		⤷ Sign Up
Germany	10085183		⤷ Sign Up
United Kingdom	0210619		⤷ Sign Up
Australia	2004201520		⤷ Sign Up
Australia	3200999		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for ALTOPREV

Recent Clinical Trials for ALTOPREV

Pharmacology for ALTOPREV

Anatomical Therapeutic Chemical (ATC) Classes for ALTOPREV

Make Better Decisions: Try a trial or see plans & pricing